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High salt content in the Western diet has been implicated in numerous disorders 1 , particularly in cardiovascular disease 2 . Guidelines 3, 4 and public initiatives recommend reducing salt intake, but an improved mechanistic understanding is needed. The deleterious effect of a high salt diet (HSD) on cardiovascular health is driven by arterial hyper tension and associated with increased morbidity and mortality 2, 5 . Thus far, most studies have focused on the role of the kidneys, the sympa thetic nervous system and direct effects on the vasculature 6 . However, some studies implicate the immune system in these processes 7 , link ing proinflammatory T cells to the development of hypertension 8 . In particular, interleukin17A (IL17A)producing CD4 + T H 17 cells may promote hypertension 9, 10 . T H 17 cells play a deleterious role in auto immune diseases. Studies have recently demonstrated that the generation of pathogenic T H 17 cells could be promoted by a high salt environment. Consequently, a HSD boosts T H 17 generation and exacerbates actively induced experimental autoimmune encephalomyelitis (EAE) 11, 12 , as a prototypic autoimmune disease driven by T H 17 cells 13 . Active myelin oligodendrocyte glycoprotein (MOG) induced EAE is a disease model that recapitulates many aspects of multiple sclerosis, although differing from transgenic EAE models in several aspects of Tcell function 14 . The intestine is exposed to varying salt loads of ingested foods, yet the interaction between HSD and the gut microbiome has not been thoroughly investigated. Gut microbes are known to respond to fluctuations in dietary composition 15 , leading to transient or persistent alterations in the gut microbiome 16 . Dietinduced shifts in micro biome composition may have profound effects on the host, especially on T cells 17 . T H 17 cells are particularly affected by the abundance of spe cific commensal bacteria 18 . We investigated the influence of highsalt challenges on the gut microbiome and the immune system, and deter mined the implications of HSD for hypertension and autoimmunity.
High salt decreases Lactobacillus in mice
To determine the effect of a HSD on the composition of the gut microbiome, we analysed faecal pellets from FVB/N mice that were fed a normal salt diet (NSD) or HSD by 16S ribosomal DNA (rDNA) gene sequencing. Both diets were equally welltolerated, indicated by similar body weight and food intake (Extended Data Fig. 1a, b) . HSDfed mice had a significantly higher fluid and salt intake than NSDfed mice (Extended Data Fig. 1c-f ), but similar intestinal transit (Extended Data Fig. 1g ). The overall microbial composition (based on operational taxonomic units, OTUs, assigned using the Ribosomal Database Project 19 ) showed no obvious pattern shifts between
A Western lifestyle with high salt consumption can lead to hypertension and cardiovascular disease. High salt may additionally drive autoimmunity by inducing T helper 17 (T H 17) cells, which can also contribute to hypertension. Induction of T H 17 cells depends on gut microbiota; however, the effect of salt on the gut microbiome is unknown. Here we show that high salt intake affects the gut microbiome in mice, particularly by depleting Lactobacillus murinus. Consequently, treatment of mice with L. murinus prevented salt-induced aggravation of actively induced experimental autoimmune encephalomyelitis and salt-sensitive hypertension by modulating T H 17 cells. In line with these findings, a moderate high-salt challenge in a pilot study in humans reduced intestinal survival of Lactobacillus spp., increased T H 17 cells and increased blood pressure. Our results connect high salt intake to the gut-immune axis and highlight the gut microbiome as a potential therapeutic target to counteract salt-sensitive conditions.
Article reSeArcH HSD and NSDfed mice (Extended Data Figs 2a, b, 3a) . Although anal yses using Jensen-Shannon divergence indicated differences between bacterial communities of HSD and NSDfed mice, these differences were not confirmed by Bray-Curtis or UniFrac 20 metrics (data not shown). Bacterial load was not significantly different between NSD and HSDfed mice (Extended Data Fig. 3b ), but several OTUs were significantly decreased after a HSD on day 14, including species of the genera Lactobacillus, Oscillibacter, Pseudoflavonifractor, Clostridium XIVa, Johnsonella and Rothia, whereas others increased after a HSD, for example, Parasutterella spp. (Extended Data Fig. 3c ). Notably, analysis of faecal metabolites from central carbon and nitrogen metabolic path ways by gaschromatography-mass spectrometry (GC-MS) showed clear differences between the two groups (Extended Data Fig. 3d-g) . The absence of largescale taxonomic differences was unexpected, given the differences in metabolites, but is consistent with the fact that the two diets are identical in energy content and only differ in salt content. To identify the specific bacterial OTUs that did change across diet, we used a sensitive machine learning approach. An AdaBoost classifier trained to distinguish NSD from HSD samples on day 14 of the treat ment identified 8 OTUs with nontrivial feature importance (Fig. 1a , c) with 92% accuracy (Fig. 1b ). These OTUs varied in maximum relative abundance (from 0.04% to 19.5%) and responded differently to the HSD (Fig. 1a, c) . OTUs identified as most important were consistent across different crossvalidation runs and across different algorithms (Extended Data Fig. 4a ). The most important OTU (25% feature impor tance) was a member of the genus Lactobacillus and was depleted after HSD ( Fig. 1d ). Other features included OTUs from Prevotellaceae, Pseudoflavonifractor, Clostridia, Parasutterella, Akkermansia, Bacteroidetes and Alistipes (Fig. 1a , c and Extended Data Fig. 4b ).
Lactobacillus depletion showed a quick onset that was detectable one day after the initiation of the HSD, remaining at low levels during the HSD with the lowest abundance on day 14. When the mice were returned to a NSD, the Lactobacillus OTU abundance returned to base line levels ( Fig. 1d ).
Because the Lactobacillus OTU was the bacterial group most strongly associated with high salt, we isolated a Lactobacillus strain from mouse faeces. The 16S rDNA sequence of the isolate shared 100% identity with the V4-V5 16S region of the OTU described above, and was identified as L. murinus. We confirmed the decrease in abundance of this strain after a HSD using qPCR ( Fig. 1e , f). Genome sequenc ing of the isolate showed 93% similarity to two published L. murinus genomes 21, 22 (Extended Data Fig. 5a ). Notably, there are no strains of L. murinus known to be native to the human microbiota; the closest 16S sequence in the human gut microbiota matches with less than 90% nucleotide identity (Extended Data Fig. 5b ). The prevalence of differ ent Lactobacillus species varies in humans; each species is present in 0.5-22% of subjects in the MetaHIT 23 subcohort of Danish subjects (Extended Data Fig. 5b ).
Next, we cultured L. murinus, humanassociated Lactobacillus spe cies and nonrelated control strains in vitro and tested their growth under increasing NaCl concentrations. Half maximal growth inhibition (IC 50 ) of L. murinus occurred at comparable NaCl concentrations under aerobic and anaerobic culture conditions (Extended Data Fig. 5c, d) . NaCl inhibited the growth of several human isolates at slightly lower concentrations, with the exception of Lactobacillus salivarius (Extended Data Fig. 5e , f). However, not all strains tested were similarly saltsensi tive. For instance, Akkermansia muciniphila, identified by the classifier and increasing in faecal abundance upon HSD, and Escherichia coli had higher salt tolerances (Extended Data Fig. 5d , g). Notably, in vivo colonic faecal sodium concentrations in HSDfed mice are comparable to growthinhibitory NaCl concentrations in vitro (0.252 M for HSD versus 0.133 M for NSD).
Because Lactobacillus species are known to metabolize tryptophan to indole metabolites 24 , we speculated that a HSD would also reduce faecal indoles. Indeed, HSD significantly reduced faecal levels of indole3lactic acid (ILA, Fig. 1g ) and indole3acetic acid (IAA, Extended Data Fig. 6a ), whereas indole3carboxaldehyde was unchanged (IAld, Extended Data Fig. 6b ). In contrast to germfree controls, mice monocolonized with the L. murinus isolate exhibited significantly higher fecal ILA, IAA and IAld, which indicates that L. murinus is capable of producing these indoles ( Fig. 1h and Extended Data Fig. 6c, d ). 
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L. murinus ameliorates active EAE
The importance of the gut microbiome has recently been recognized for multiple sclerosis 25 and EAE 26 . The suppression of L. murinus by HSD prompted us to investigate whether oral administration of L. murinus ameliorates HSDinduced exacerbation of actively induced MOG EAE.
We relied on a daily gavage protocol to maintain L. murinus abun dance and faecal indole metabolites during HSD. Body weight and disease incidence were similar in all groups. Mice on a HSD displayed an exacerbated disease course ( Fig. 2a and Extended Data Fig. 7a ). L. murinus supplementation during HSD and NSD feeding amelio rated the disease ( Fig. 2a and Extended Data Fig. 7a , b). Similar results were observed when HSDfed mice were treated with Lactobacillus reuteri (Extended Data Fig. 7c ). We analysed CD4 + small intestinal lamina propria lymphocytes (siLPL) producing IL17A by flow cyto metry on day 3 after MOG immunization when intestinal T H 17 cell expansion was at its maximum 27 . HSDfed mice had a significantly higher frequency of T H 17 cells compared to NSDfed mice, and this frequency was reduced in HSDfed mice that concomitantly received Lactobacillus murinus (Fig. 2b ). Flow cytometry analysis of splenocytes and spinal cordinfiltrating lymphocytes on day 17 after immuniza tion revealed a significant reduction in T H 17 cells after treatment with L. murinus ( Fig. 2c, d ) and L. reuteri (Extended Data Fig. 7d , e) com pared to HSD feeding alone. mRNA expression of Il17a and Rorc in spinal cord tissue was decreased after L. murinus treatment with a tendency towards lower Csf2 levels (Extended Data Fig. 7f -h). The effect of HSD and L. murinus was mostly T H 17specific, because interferonγ (IFNγ)producing CD4 + lymphocytes were not affected in the siLPL, spleen or spinal cord (Extended Data Fig. 7i ). Because we focused on actively induced MOG EAE, further studies are needed to extend the concept of HSD and Lactobacillus treatment in spontaneous EAE.
To elaborate on putative mechanisms for the modulation of T H 17 cells, we focused on faecal indole metabolites, which are known to improve actively induced EAE 28 . HSD significantly reduced faecal ILA, whereas concomitant L. murinus supplementation prevented this effect ( Fig. 3a, b ). A similar pattern was observed for faecal IAA and IAld (Extended Data Fig. 7j -m). Next, we investigated the effect of ILA on the differentiation of mouse T H 17 cells in vitro. ILA significantly reduced T H 17 polarization in a dosedependent manner ( Fig. 3c ).
However, in MOG immunized germfree mice, HSD did not change T H 17 cell frequencies compared to NSD (Extended Data Fig. 8a, b ), indicating a crucial role for intestinal bacteria in mediating the effect of a HSD on T H 17 cells. To corroborate the modulatory effects of L. murinus, we used segmented filamentous bacteria (SFB) as known inducers of intestinal T H 17 cells 18 and compared MOG immunization in gnotobiotic mice that had either only SFB (germfree with SFB) or SFB and L. murinus (germfree with SFB and L. murinus). As predicted, the presence or absence of L. murinus determined T H 17 cell frequencies in siLPL and colonic LPL (cLPL) (Extended Data Fig. 8c, d ).
L. murinus reduces salt-sensitive hypertension
Accumulating evidence suggests that T H 17 cells have a role in the genesis of hypertension 7 . Moreover, a recent metaanalysis provided preliminary support that Lactobacillusrich probiotics might affect blood pressure in hypertensive subjects 29 . Therefore, we tested whether L. murinus treatment decreased experimental saltsensitive hypertension.
Blood pressure increased over three weeks of HSD ( Fig. 4a, b and Extended Data Fig. 9a ). Concomitant daily treatment with L. murinus led to a significant reduction in systolic blood pressure and normal ization of diastolic blood pressure (Fig. 4a, b and Extended Data Fig. 9b , c). L. reuteri was similarly effective, whereas the nonLactobacillus strain E. coli Nissle 1917 was ineffective (Extended Data Fig. 9d -g).
We next asked whether L. murinus treatment affects T H 17 cells in experimental saltsensitive hypertension and analysed intestinal and splenic lymphocytes by flow cytometry. Compared to NSD, a HSD led to a significant increase in CD4 + RORγ t + T H 17 cell frequencies in siLPL, which was significantly reduced by L. murinus treatment (Fig. 4c ). In addition, flow cytometry analysis of siLPL, cLPL and splenic lymphocytes revealed a significant reduction in T H 17 cell frequencies by L. murinus treatment compared to HSD feeding alone ( Fig. 4d-f ). The effect of HSD and concomitant L. murinus treatment on effector T cells was again mostly specific to T H 17 cells, as a similar pattern was not observed for T H 1 markers. Except in the siLPL, HSD and L. murinus treatment did not alter the expression of the T H 1 cytokine IFNγ (Extended Data Fig. 9 h-j). In addition, the frequencies Article reSeArcH of regulatory CD4 + CD25 + Foxp3 + T (T reg ) cells were not significantly affected by either the HSD or concomitant L. murinus treatment in intestinal and splenic tissues (data not shown). Thus, L. murinus prevents HSDinduced generation of T H 17 cells and consequently ameliorates saltsensitive hypertension.
Salt challenge in healthy humans
To corroborate our findings in humans, we conducted an explora tory pilot study in healthy male volunteers, where participants were subjected to an increased salt intake for 14 days. Participants received 6 g sodium chloride per day (corresponding to 2.36 g Na + per day) using slowrelease NaCl tablets in addition to their accustomed diets. According to dietary records, salt intake from foods and drinks was similar between baseline and on day 14 of high salt intake. During the highsalt challenge, the total salt intake was 13.8 ± 2.6 g per day (Extended Data Fig. 10a ). We monitored ambulatory blood pressure at baseline and after salt challenge in a subgroup of 8 participants. To standardize blood pressure measurements and exclude physical activity or stressdriven alterations during daytime 30 unrelated to salt sensitiv ity, we monitored nocturnal blood pressure during bed rest. Compared to baseline, the highsalt challenge significantly increased mean noc turnal systolic and diastolic blood pressure ( Fig. 5a ). Because the HSD increased the number of T H 17 cells in mice, we analysed T H 17 cells in human blood before and after the highsalt challenge. Analysis of peripheral blood lymphocytes using flow cytometry revealed a signi ficant increase in CD4 + IL17A + TNF + T H 17 cells ( Fig. 5b) .
To investigate the effect of a highsalt challenge on the human gut microbiome, we analysed the abundance of Lactobacillus species in faecal samples before and after the highsalt challenge. To achieve a more detailed taxonomic resolution, a full shotgun metagenomic analysis was performed (see Supplementary Information) . Lactobacillus is not a dominant member of the human faeces. In a previously published control dataset 31, 32 , 41.3% of subjects were positive for any Lactobacillus species. In our present study, similarly, 5 out of 12 (41.7%) subjects were positive for at least one gut Lactobacillus species at baseline ( Fig. 5c ). Overall, we detected seven different gut Lactobacillus species at baseline ( Fig. 5c , species assignment using the species identification (SpecI) 33 metagenomic analysis framework). After the highsalt challenge, nine out of ten Lactobacillus populations that were initially present could no longer be detected in the respective study subjects, suggesting a loss of Lactobacillus species (Supplementary Information and Extended Data Fig. 10b-d for crossvalidation). To test whether this is expected for the human gut over time, we reanalysed 121 published Illumina sequenced healthy gut metagenomes 31, 32 with time course informa tion. A Kaplan-Meier survival analysis on all Lactobacillus populations revealed a significantly decreased survival (defined here as continued detectability) rate of Lactobacillus gut populations with a HSD (Fig. 5d ). Compared to nonLactobacillus species, Lactobacillus strains were lost significantly faster with a HSD, reflecting the effect of high salt on a taxon with an intrinsically low resilience (Supplementary Information and Extended Data Fig. 10e, f) . Furthermore, we observed that several study subjects had gained at least one new Lactobacillus species by day 14 that had not been detected at baseline (Extended Data Fig. 10g -i). We speculate that this is the consequence of ingested Lactobacillus containing foods, since study participants were not subjected to dietary restrictions. Therefore, a highsalt challenge induces an increase in blood pressure and T H 17 cells in healthy subjects, alongside reducing survival of intestinal Lactobacillus species in subjects with Lactobacillus at baseline.
Discussion
Here we show the effect of increased salt consumption on intestinal bacteria in mice and humans and expand the existing knowledge on the effects of this nutrient. Several intestinal bacteria were affected by high salt; particularly, Lactobacillus spp. were suppressed. In addition, faecal metabolites levels, particularly bacterial tryptophan metabolites, responded to HSD in mice. Such effects may contribute to salt induced T H 17 cell responses and saltsensitive conditions. Because L. murinus produces ILA, we speculate that its saltinduced decrease with reduced ILA generation could be responsible for an increased T H 17 cell response. Importantly, the experimental approaches in mice demonstrate that L. murinus supplementation blunts HSDinduced T H 17 activation and ameliorates saltsensitive hypertension and actively induced EAE in vivo. However, actively induced EAE differs from spontaneous disease models 14 . It is therefore currently unclear whether high salt effects can be generalized beyond the actively induced model and to multiple sclerosis. These limitations may also extend to the recent controversy regarding the more general effects of a HSD on neuroinflammation 34, 35 . However, in the actively induced EAE and hypertension models used here, and in humans, high salt increased T H 17 cell frequencies.
Lactobacillus metabolites are known to affect host physiology 24, 36 and ameliorate actively induced EAE 28 . Other tryptophan metabolites have been shown to reduce blood pressure 37 . Our data in mice suggest that L. murinus may substantially influence the abundance of faecal trypto phan metabolites, although we cannot exclude the possibility that other strains (for example, Bifidobacterium spp.) may be producers of similar importance. Additionally, we demonstrated that ILA inhibited mouse polarization of T H 17 cells in vitro, a finding that needs to be addressed in more detail in vivo. These results highlight the microbiome as a saltsensitive compartment but do not speak against a more direct effect of high salt on host cells. Earlier investigations have shown that the ionic microenvironment directly affects various immune cells [38] [39] [40] [41] . Salt intake also has profound actions on hormonal systems, such as the renin-angiotensin-aldosterone axis.
Our pilot study in humans is limited in power and needs to be validated in a larger cohort. Considering this limitation, it suggests that even a moderate salt challenge may affect the persistence of intestinal 
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Lactobacillus strains and other bacteria, along with an increase in proinflammatory T H 17 cells and saltsensitive blood pressure changes. Interestingly, newborn infants have the greatest abundance of Lactobacillus species, which decreases over time 42, 43 . Compared to microbiomes from indigenous populations, abundance of Lactobacillus strains in 'Western' gut microbiomes is low 44 . Salt ingestion that already starts at a young age may partially have contributed to the relative loss of Lactobacillus strains from Western microbiomes and thereby may have role in the development of hypertension and autoimmunity.
Finally, the development of microbiotatargeted therapies is an intriguing new avenue for many diseases. Nevertheless, changes in microbiome composition or function must first be carefully shown to contribute to any disease. Our experimental data in mice suggest that the gut microbiota might serve as a potential target to counteract salt sensitive conditions. The identification of Lactobacillus as a 'natural inhibitor' of high saltinduced T H 17 cells in mice could serve as a basis for the development of novel prevention and treatment strategies. It is up to randomized controlled trials in humans with diseases to test this hypothesis. Moreover, any future dietary salt intervention trial should thus consider monitoring the microbiome to expand on our observations.
MethOdS
Animal ethics. All animal experiments were conducted in accordance with insti tutional, state and federal guidelines and with permission of the local animal ethics committees (Landesamt für Gesundheit und Soziales Berlin, Germany; Regierung Unterfranken, Würzburg, Germany; Ethical Committee for Animal Experiments, Hasselt University, Belgium). Male mice were maintained on a 12:12 h day:night cycle with constant access to food and water. Mouse high salt feeding and faeces collection. All normal salt (NSD, E15430047) and high salt (HSD, E1543134) purified diets used for mouse experiments were purchased from Ssniff (Soest, Germany). Diets were gammairradiated (25 kGy) and identical in composition except for NaCl content (NSD: 0.5% NaCl, HSD: 4% NaCl). Drinking water for HSD animals was supplemented with 1% NaCl.
For faecal microbiome analyses, male FVB/N mice aged 12 weeks were pur chased from Charles River and accustomed to NSD. Control animals remained on the NSD (n = 8), others were switched to HSD (n = 12) for 14 days. A subgroup was switched back to NSD for another 14 days (n = 8). Body weight and food intake were monitored. To avoid cage effects, mice were housed individually. Fresh faecal pellets were collected directly from the anal orifices, immediately flashfrozen in liquid nitrogen and stored at − 80 °C for later analyses. DNA extraction from mouse faeces and 16S sequencing. DNA was extracted from a single faecal pellet from each mouse using the Power Soil kit (MO BIO Laboratories). The protocol was modified from the manufacturer's instructions to include proteinase K treatment to further lyse the cells. After addition of proteinase K (final concentration 5 mg ml −1 ) samples were incubated at 65 °C for 10 min and a further 10 min at 95 °C. Plates were inverted to mix during both incubations. The V4 region of the 16S rRNA gene was amplified with 515F and 806R primers 45 using a twostep PCR library preparation as previously described 46 . An Illumina MiSeq was run for 250 cycles to produce pairedend reads. 16S rDNA data processing. The raw sequences were demultiplexed, allow ing at most 2 mismatches in the barcode before discarding a sequence. Primers sequences were removed, allowing at most 2 mismatches in the primer sequence before discarding a sequence. Forward and reverse reads were merged by com paring alignments with lengths of 253 ± 5 nucleotides. The alignment with the fewest mismatches was used unless the number of mismatches was greater than 2, in which case the read pair was discarded. Merged reads were filtered for quality by removing reads with more than 2.0 expected errors 47 . Each unique sequence was assigned a taxonomy using the ribosomal database project 48 , truncating the taxonomy to the highest taxonomic level with at least 80% support. Sequences that were assigned the same taxonomy were then placed in the same OTU. De novo OTUs were also called using usearch 49 . 16S rDNA data analysis. For most analyses, three samples were excluded because their read counts were low (< 1,000 counts). The MDS ordination and PERMANOVA test were computed using the vegan package 50 in R. The phyloge netic tree was generated from a single medoid sequence from each OTU. Medoid sequences were selected by aligning all the sequences in each OTU with PyNAST 51 , computing a distance matrix with Clustal Omega 52 , and selecting the medoid sequence. Aligned sequences with at least 10 reads in their corresponding OTU were assembled into a tree with FastTree v.2.0 (ref. 53 ) and visualized with the ape package 54 in R. The AdaBoost classifier 55 was run with 10 7 estimators using the scikitlearn module 56 in Python. The random forest classifier 57 was run with 10 6 estimators also using the scikitlearn module in Python. Faecal metabolite analysis. An extraction mixture of methanol:chloroform:water (MCW; 5:2:1 vv:v) (methanol LC-MSgrade, chloroform, Reagent Plus 99,8% SigmaAldrich) with cinnamic acid (2 μ g ml −1 , SigmaAldrich) as internal stand ard was added to the sample. Samples were dissolved in MCW (1 ml per 60 mg of sample) using the tissue lyser (Precellys 24 lysis and homogenization, Bertin Technologies), samples were cooled on ice between the shaking cycles. Samples were shaken at 1,000 r.p.m. and 4 °C for 60 min. After addition of icecold water (half of the MCW volume), samples were shaken at 1,000 r.p.m. and 4 °C for 10 min. Samples were centrifuged for 10 min at 14,000 r.p.m. to separate the polar (top), lipid (bottom) and interface (tissue debris) layers. the polar phase containing metabolites was dried under vacuum for 12 h.
Samples were derivatized as follows: the dried extracts were dissolved in 20 μ l of methoxyamine hydrochloride solution (SigmaAldrich; 40 mg ml −1 in pyri dine (Roth)) and incubated for 90 min at 30 °C shaken at 1,000 r.p.m. followed by the addition of 40 μ l of NmethylN[trimethylsilyl]trifluoroacetamide (MSTFA; MacheryNagel) and incubation at 37 °C for 45 min agitated at 1,000 r.p.m. The extracts were centrifuged for 10 min at 14,000 r.p.m., and aliquots of 30 μ l were transferred into glass vials (Chromacol) for GC-MS measurements. Metabolite analyses were performed with a Pegasus IV mass spectrometer (LECO) as described previously 58 . The GC-MS chromatograms were preprocessed with the ChromaTOF software (LECO). Calculation of retention index, mass spectra identification and metabolite quantification were performed using the inhouse MauiSILVIA software tool 59 .
Measured values from 66 metabolites were obtained. Because a paired analysis (metabolites at NSD baseline versus metabolites after HSD) was performed, absence of a given value made the exclusion of the corresponding second value necessary. This was in only 33 out of 1,056 cases (3.1%). A small pseudocount value (0.001) was added to all metabolite values and data were log 10 transformed. Data from each metabolite were normalized by subtracting the minimum and dividing by the maximum value across all eight mice. A PCA was performed using the PCA module in the scikitlearn package of Python. The heat map was prepared with the clustermap function of the Seaborn package. Measurement of tryptophan metabolites. Faecal pellets derived from mice were processed as previously described 24 . Chemicals used were purchased from Sigma Aldrich and were liquid chromatography (LC)-MS grade. Pellets were diluted in 0.2 M acetate buffer (pH 4.2) at 300 μ l per 10 mg faeces and shaken with 1.5 ml methyl tertbuthyl ether (MTBE) on a shaker at room temperature at 1,400 r.p.m. for 10 min in the presence of ceramic beads (2.8 mm Precellys Ceramic Beads, Peqlab). Samples were afterwards centrifuged at 4 °C at 9,000g. From the organic phase, 1 ml was transferred into a new Eppendorf vial and samples were con centrated using an Eppendorf Concentrator 5301. Concentrated samples were dissolved in 200 ml acetonitrile:H 2 O 1:4 vv containing 0.2% formic acid and stored at -20 °C for further analysis.
LC-MS/MS analysis was performed using an Agilent 1290 Infinity II UPLC system coupled to an Agilent 6495 Triple Quad mass spectrometer equipped with an iFunnel ESI ion source operated in positive mode (Agilent Technologies). The UPLC column used was an Agilent Eclipse plus (100 mm × 2.1 mm, 1.8 μ m). Chromatography was performed under gradient conditions using mobile phase A (0.1% formic acid in water) and B (0.1% formic acid in methanol). The gradient was started at 5% methanol, increased to 95% after 10 min with a constant flow rate of 0.3 ml min −1 during a total run time of 17 min. The column temperature was set to 30 °C. The injection volume was 1 μ l. Drying gas was adjusted at 130 °C per 17 l min −1 , sheath gas at 400 °C per 11 l min −1 . Capillary and nozzle voltage were optimized at 3,500 V and 800 V, respectively. Analytes were monitored in the multiple reaction monitoring mode. The optimal transitions, collision energies and cell accelerator voltages for each compound were determined as follows: ILA: 206 → 118 m/z, CE: 24 V, CAV: 1 V; IAld 146 → 118 m/z, CE: 13 V, CAV: 5 V; IAA 176 → 130 m/z, CE: 17 V, CAV: 1 V. Calibration curves for the quantification of individual metabolites were established based on the changes in the relative peak area in response to different target compound concentration. Linearity was r 2 > 0.99 over a range of 0.05-300 ng ml −1 for any compound. Isolation of L. murinus. Faecal samples from healthy male NSDfed FVB/N mice were dissolved and diluted at a 1:10 dilution in anaerobic phosphatebuffered saline (PBS) (pH 7.6) containing lcysteine HCl at 0.1% in a Coy Anaerobic Chamber (5% H 2 , 20% CO 2 , 75% N 2 ). Samples were diluted tenfold and each dilution spread on LAMVAB agar 60 . Plates were incubated at 37 °C under anaerobic conditions and examined for growth at 24 h. Individual colonies growing at the highest dilution were picked into LAMVAB medium and grown for an additional 16 h. Liquid cul tures were stored in 15% DMSO. For identification of isolates, DNA was extracted by adding 5 μ l liquid culture to 20 μ l sterile distilled water and storing at 4 °C over night; 2 μ l of this extract was amplified with Phusion HF polymerase in a 20μ l reaction using universal 16S primers 27F (5′ AGAGTTTGATCMTGGCTCAG3′ ) and 1492R (5′ TACGGYTACCTTGTTACGACTT3′ ). PCR products were puri fied using Agencourt AMPure XP and submitted with the 27F primer for Sanger sequencing. An isolate for which the fulllength 16S sequence shared 100% identity with the V4-V5 region of the Lactobacillus species identified in the 16S library was selected for further study. Frozen stocks of L. murinus (in PBS with 25% glycerol) were prepared, stored at − 80 °C and used for gavage of saltsensitive and EAE mice. Salt tolerance of L. murinus and selected gut commensals. Frozen stocks of L. murinus were streaked onto MRS agar and incubated at 37 °C under aerobic conditions for 24 h. Single colonies were picked into MRS medium and grown until midlog phase (OD 600 = 0.4-0.6), at which time liquid cultures were diluted 1:100 into MRS medium containing NaCl in the range of 0-2 OsM. In separate experi ments, E. coli and L. murinus were picked into LB (E. coli) or MRS (L. murinus) medium. The Na + concentration of growth medium was determined using atomic absorption spectrometry or calculated. The OD 600 of cultures was measured after an additional 12-16 hours of growth. For comparison of the salt tolerance of phylo genetically distinct gut commensals, C. difficile ATCC 700057, A. muciniphila DSM 26127 and P. excrementihominis DSM 21040 were cultured under the same conditions. Frozen stocks of each strain, along with L. murinus, were streaked onto Brucella Blood Agar with vitamin K and haematin, and grown at 37 °C in a Coy Anaerobic Chamber for 24 h. Individual colonies were transferred into liquid Gifu anaerobic medium supplemented with 0.25% porcine gastric mucin (SigmaAldrich) and grown until midlog phase, at which time they were diluted 1:100 into MGAM containing NaCl with concentrations of Na + ranging from 0.08 to 1.8 M. OD 600 of cultures was measured after 48 h of growth (to compensate for the slow growth rates of some of the strains). ATCC SD5275) . Lactobacillus strains were grown anaero bically in a gas chamber (Coy Laboratory Products; 12% CO 2 , 2.5-5% H 2 and 83-85.5% N 2 ) in Gifu Anaerobic Medium Broth (MGAM) at 37 °C. Overnight cultures were diluted to an initial OD of 0.01 and growth was assessed in the pres ence of increasing concentrations of NaCl by monitoring the absorbance at 578 nm using an Eon (Biotek) microplate spectrophotometer at 30min intervals after 30 s of shaking. AUCs were calculated using the trapezoidal rule and normalized to the AUC calculated for growth in MGAM without addition of NaCl. Germ-free mice and L. murinus monocolonization. C57BL/6J male mice were bred under germfree conditions and kept in a 12h light cycle and fed sterile NSD (E15430047, Ssniff) ad libitum. For monocolonization, mice were gavaged with 200 μ l of L. murinus stock solution (10 7 CFU ml −1 , as described above) and further maintained under sterile conditions for two weeks. Faecal pellets were collected under sterile conditions and immediately frozen in liquid nitrogen, or cultured in liquid thioglycolate medium (bioMerieux), incubated for seven days, streaked on sheep blood agar plates (Oxoid, 24 h) and further analysed for species identification using MALDI-TOF (analysed by GIMmbH) as described previously 61 . Salt-sensitive hypertension in mice. To induce saltsensitive hypertension, the lNAME/salt mouse model was used as described previously 62 . This nonsurgical intervention closely recapitulates saltsensitive hypertension common in humans 62 . In brief, NSDfed male FVB/N mice, aged 10-12 weeks, received pretreatment with lNAME (0.5 mg ml −1 , SigmaAldrich) in drinking water for three weeks, followed by a oneweek washout period with NSD and normal drinking water. Then, mice were switched to either HSD with oral administration of L. murinus (daily gavage of 200 μ l 10 7 CFU ml −1 L. murinus suspension), HSD with oral administration of control solution (daily gavage of 200 μ l PBS:glycerol) or NSD for two weeks. For blood pressure measurements, mice were implanted with miniature subcu taneous radiotelemetry devices under anaesthesia (Data Sciences International) before the lNAME/salt protocol. Thereby, systolic and diastolic blood pressures were recorded continuously at 5min intervals in freely moving mice. Following hypertension induction with HSD for three weeks, HSD was continued and mice were concomitantly gavaged with 200 μ l 10 7 CFU ml −1 L. murinus in PBS and glycerol daily. L. reuteri and E. coli Nissle 1917 were used for separate experiments in a similar manner (10 7 CFU ml −1 in PBS and glycerol daily).
In vitro growth of human-associated
Mice were euthanized under anaesthesia and spleens and intestines were col lected. Singlecell suspensions of the small intestinal (si) and colonic (c) lamina propria lymphoyctes (LPL) were obtained by enzymatic and mechanical dissocia tion using the Mouse Lamina Propria Dissociation kit (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's protocol. Cell debris was removed using a Percoll (GE Healthcare) density gradient centrifugation as described previously 63 . Splenocyte singlecell suspensions were obtained using 70μ m strainers, followed by erythrocyte lysis and subsequent filtering using a 40μ m mesh. Cells were counted by trypan blue exclusion and labelled for flow cytometry analysis.
Isolated immune cells were either directly stained for surface markers using the respective fluorochromeconjugated antibodies (30 min in PBS supplemented with EDTA and BSA) or restimulated with 50 ng ml −1 phorbol12myristate13acetate (PMA, SigmaAldrich), 750 ng ml −1 ionomycin (SigmaAldrich) and 0.75 μ l ml −1 GolgiStop (BD Bioscience) for 4 h at 37 °C and 5% CO 2 in RPMI 1640 medium (SigmaAldrich) supplemented with 10% FBS, 1% penicillin-streptomycin. For all measurements, dead cell exclusion was performed using a fixable viability dye for 405 nm (Thermo Fisher). For intracellular staining, cells were permeabilized and fixed using the FoxP3 Staining Buffer kit (eBioscience) and labelled using the respective antibodies. Antibodies used are listed below. Cells were analysed with the BD FACSCanto II flow cytometer and BD FACSDiva software (BD Bioscience). Data analysis was performed with FlowJo v.10 (FlowJo LLC). Experimental autoimmune EAE. Male C57BL/6J mice (Charles River), aged 10-12 weeks, were either fed a NSD, a HSD (Ssniff, as described above) with oral administration of L. murinus or L. reuteri (daily gavage of 200 μ l 10 7 CFU ml −1 suspension) or a HSD with oral administration of solvent (daily gavage of 200 μ l PBS:glycerol). EAE was induced as described previously 11 . In brief, mice were anaesthetized and subcutaneously injected with 200 μ g MOG and 200 μ g CFA. Pertussis toxin (200 ng per mouse) was applied intraperitoneally on days 0 and 2 after immunization. Clinical symptoms were assessed daily according to a fivepoint scale ranging from 0 (no symptoms) to 5 (moribund) 11 . For disease courses, only mice with clinical symptoms were included.
On day 17 after immunization, mice were euthanized under anaesthesia and CNS tissue was collected, disrupted with a 5ml glass homogenizer and strained through a 100μ m cell strainer. The CNS cell suspension was resuspended in 6 ml 30% isotonic Percoll (GE Healthcare) for a threestep density gradient. Lymphocytes were collected from the interphases, washed and further analysed by flow cytometry. Spleens were disrupted with a glass homogenizer, filtered through a 100μ m cell strainer and treated with 0.14 M ammonium chloride to lyse eryth rocytes. To analyse the early inflammatory response in the small intestine, a subset of mice was euthanized on day 3 after immunization and the small intestine was collected and processed as described above to obtain LPL.
In two additional experimental setups EAE was induced in male germfree C57BL/6J mice fed gammasterilized (50 Gy) NSD or HSD diets. First, germfree mice were fed with either NSD or HSD (two weeks before immunization and thereafter). Second, germfree mice were fed a NSD and either monocolonized with SFB (by introduction of faeces from SFB monocolonized mice) or SFB and L. murinus. In both experimental subgroups, intestines were collected on day 3 after immunization for flow cytometry analyses.
Singlecell suspensions were analysed by staining for extra and intracellular markers. Dead cells were excluded by a fixable viability dye eFluor780 (eBiosci ence), Fcblock was performed using antiCD16/32 antibody (eBioscience). For intracellular cytokine staining, cells were stimulated with ionomycin (1 μ M) and PMA (50 ng ml −1 ) in the presence of monensin (2 μ M) for 4 h. Cells were stained for surface markers with the respective fluorochromeconjugated antibodies for 30 min and permeabilized using Fixation and Permeabilization Buffer (eBio science) according to the manufacturer's protocol. Intracellular cytokines were labelled with the respective fluorochromeconjugated antibodies for 30-45 min. For antibodies used see below. Cells were analysed with the BD FACSCanto II flow cytometer and BD FACSDiva software (BD Bioscience). Data analysis was performed with FlowJo (LLC).
For quantitative realtime PCR, tissue was homogenized in 500 μ l peqGOLD TriFast with an UltraTurrax for 30 s followed by total RNA isolation with PerfectBind RNA Columns (peqGOLD HP Total RNA Kit, Peqlab). RNA yield was quantified by absorbance measurements at 260 nm and reverse transcribed into cDNA using QuantiTect transcriptase (Qiagen). PCR reactions were performed at a 5μ l scale on a qTower realtime PCR System (Analytic Jena, Germany) in triplicates using Taqman Assays (Thermo Fisher) for Il17a (Mm00439618_m1), Rorc (Mm01261019_g1) and Csf2 (Mm01290062_m1). Relative quantification was performed by the Δ Δ C t method, normalizing target gene expression to Actb (β actin; Mm00607939_s1) as housekeeping gene. Antibodies used for flow cytometry of mouse cells. AntiCD3ε -FITC and antiCD3ε -VioBlue (clone 17A2, Miltenyi Biotec), antiCD4-APC-Vio770 (clone GK1.5, Miltenyi Biotec), antiCD4-Pacific blue and antiCD4-FITC (clone RM4 5, BD), antiCD25-VioBlue and antiCD25-FITC (clone 7D4, Miltenyi Biotec), antiFoxP3-PerCP-Cy5.5 (clone FJK16s, eBioscience), antiIFNγ -PE-Cy7 and antiIFNγ -APC (clone XMG1.2, eBioscience), antiIL17A-PE (clone eBio17B7, eBioscience) and antiRORγ t-APC (clone REA278, Miltenyi Biotec). Electrolyte analysis of mouse faeces. Faecal samples from NSD and HSDfed mice were collected and stored at − 80 °C until further analysis. n = 7-9 faeces samples were pooled, weighed and then processed as described previously 64 . In brief, samples were weighted, desiccated, ashed, dissolved and measured for Na + concentration by atomic adsorption spectrometry (Model 3100, Perkin Elmer). Measurement of intestinal transit. Male FVB/N mice were fed a NSD or HSD for 14 days. Mice were administered activated charcoal (0.5 g per 10 ml in 0.5% methylcellulose; 0.1 ml per 10 g body weight by oral gavage). After 20 min, mice were euthanized and the distance travelled by charcoal was measured. High-salt challenge study in healthy humans. We performed an openlabel clini cal pilot study to investigate the effect of an increased salt intake on cardiovascular and immunoregulatory functions in healthy men (https://clinicaltrials.gov/ iden tifier: NCT02509962). The study was conducted at the Experimental and Clinical Research Center Berlin (ECRC), Germany, in accordance with the ethical stand ards of the institutional review board. The institutional review board of Charité University Medicine Berlin approved the study (EA1/138/15) and written informed consent was obtained from all participants before study entry. Key inclusion criteria were male, age 18-50 years and a body mass index between 18.5 and 29.9 kg m −2 . Key exclusion criteria were any cardiovascular, metabolic (diabetes), autoimmune, liver and kidney diseases, alcohol or drug abuse. To increase salt intake, subjects (n = 12, included until March 2016, for baseline characteristics see Supplementary Information) received 10 coated tablets daily (three with breakfast, three with lunch and four with dinner) for two weeks, each tablet containing 600 mg sodium chlo ride in a slow release formulation (Slow Sodium Tablets, HK Pharma Ltd), yielding
Article reSeArcH an increase of habitual salt intake by 6 g per day. Subjects were asked not to change their dietary habits during the study. Sodium intake from ingested foods and drinks was calculated from dietary records of three consecutive days using OptiDiet Plus software v.5.1.2 (GOE mbH), a professional analysis software that is based on nutri tional content of food as provided by the German Nutrient Database 65 .
Stool samples were collected at baseline and on day 13 of the highsalt chal lenge from all 12 subjects. In brief, subjects collected fresh faecal samples using disposable toilet seat covers (Süsse Labortechnik) and plastic vessels with spatula (Sarstedt AG). Closed vessels with faecal samples were immediately frozen in a domestic freezer at -20 °C and subsequently transferred to the study centre on dry ice, where samples were stored at -80 °C until further use.
At baseline and on day 13 of the highsalt challenge, 8 subjects received ambu latory blood pressure monitors (ABPM, MobilOGraph, I.E.M. GmbH) for noc turnal blood pressure monitoring (measurements at bed rest every 30 min, subjects indicated bed rest by pressing the day/night button of the ABPM).
Venous blood was taken at baseline and on day 14 of the HSD for immediate isolation of peripheral blood mononuclear cells. Metagenomic sequencing of human faecal samples. Samples were processed, extracted and sequenced as previously described 32 with SpecI 33 and mOTU 66 taxonomic abundances estimated using MOCAT 67 . Because Lactobacillus has a low abundance in the human gut, to verify results are robust to changes in the bio informatic protocol, samples were additionally processed using the complementary tool MetaPhlan 68 , which uses lineagespecific marker genes as opposed to the universal marker genes informing SpecI and mOTU species quantification, with MetaPhlan species detection results almost identical to mOTU species detection results (Extended Data Fig. 10a, b) .
Previously published healthy human gut shotgun metagenomes where multiple samples from the same individual at different time points were available were taken from ref. 32 and from the Human Microbiome Project (2012, processed as described previously 31 ). Survival analysis was done using the survival package 69 in R as outlined in ref. 70 . Human blood cell analysis. Peripheral venous blood was obtained from study participants. Peripheral blood mononuclear cells were immediately isolated by density centrifugation using Biocoll (Merck). Subsequently, 10 6 CD4 + enriched cell fractions isolated using the CD4 + T Cell kit (Miltenyi Biotec) were plated onto Ubottom plates and were restimulated for 4 h at 37 °C, 5% CO 2 in a humid ified incubator. Restimulation was conducted in a final volume of 200 μ l RPMI 1640 (SigmaAldrich) supplemented with 10% FBS (Merck), 100 U ml −1 peni cillin (SigmaAldrich), 100 mg ml −1 streptomycin (SigmaAldrich), 50 ng ml −1 PMA (SigmaAldrich), 250 ng ml −1 ionomycin (SigmaAldrich) and 1.3 μ l ml −1 Golgistop (BD). After restimulation, cells were stained with the Life/Dead Fixable Aqua Dead Cell kit (Thermo Fisher) and monoclonal CD3-PerCP-Vio700 anti body (clone BW264/56, Miltenyi Biotec). Cells were fixed and permeabilized with the Foxp3/Transcription Factor Staining Buffer kit (eBioscience) and labelled using antiIL17A-APC-Vio770 (clone CZ82361, Miltenyi Biotec) and anti TNF-eFluor450 (clone Mab11, eBioscience) monoclonal antibodies. Cells were analysed using a FACSCanto II flow cytometer and FACSDiva software (BD). Data analysis was performed with FlowJo (LLC). Mouse T H 17 cell polarization. Splenic T cells were isolated by magneticactivated cell sorting using the Pan T cell isolation kit II (Miltenyi Biotec) according to the manufacturer's instructions. Isolated T cells were collected and resuspended in MACS buffer at 3 × 10 7 cells per ml. For APCfree differentiation, cells were fluorescently stained for 30 min in an antibody cocktail containing antiCD4-FITC (RM45, eBioscience), antiCD44-PE (IM7, BioLegend), antiCD62L-APC (MEL14, eBioscience) and antiCD25-PE-Cy5 (PC61.5, eBioscience) and sub sequently purified by fluorescenceactivated cell sorting on MoFlo (Beckman Coulter). Sorted naive T cells (CD4 + CD62L + CD44 low CD25 − ) were stimulated by platebound antiCD3 (2 μ g ml −1 , 1452C11, BD Pharmingen) and antiCD28 (2 μ g ml −1 , 37.51, BD Pharmingen) in the presence of IL6 (40 ng ml −1 ) and rhT GFβ 1 (2 ng ml −1 ). To determine the influence of ILA on T H 17 cell differentiation, cells were cultured with vehicle (0.1% ethanol) or 10-500 μ M ILA for 96 h under isotonic or hypertonic (+ 40 mM NaCl) conditions. DNA extraction from faeces and qPCR of 16S rRNA genes. DNA from stool samples was isolated using QIAamp DNA Stool Mini Kit (Qiagen) according to the manufacturer's instructions. To optimize the representation of the bacterial com munity structure, a mutanolysin (SigmaAldrich) digestion step was included (6 μ l of 25 kU ml −1 stock per sample) 71 . qPCR on a 7500 Sequence Detector (Applied Biosystems, AB) was used to calculate the number of bacterial 16S rRNA gene copies in the genomic DNA extracted from stool samples. Samples were quantified in 10μ l reactions containing 1× SYBR Green Master Mix (AB), 300 nM of each primer and 4 ng of genomic DNA. Standard curves for quantification consisted of tenfold serial dilutions in the range of 10 8 -10 0 copies of the 16S rRNA gene of the E. coli (Invitrogen, C404010) or L. murinus isolates amplified with primers 27F (5′ GTTTGATCCTGGCTCAG3′ ) and 1492R (5′ CGGCTACCTTGTTACGAC3′ ) 72 . The total amount of bacterial 16S in stool samples was quantified with univer sal primers, Univ 337F 5′ ACTCCTACGGGAGGCAGCAGT3′ and Univ 518R 5′ GTATTACCGCGGCTGCTGGCAC3′ 73 . The total amount of different Lactobacillus DNA in stool samples was quantified using the following primers: L. murinus/animalis 74 , LactoMF (5′ TCGAACGAAACTTCTTTATCACC3′ ) and LactoMR (5′ CGTTCGCCACTCAACTCTTT3′ ); L. brevis 75 , LbrevF (5′ TGCACTGATTTCAACAATGAAG3′ ) and LbrevR (5′ CCAGAAGTG ATAGCCGAAGC3′ ); L. casei/paracasei 76 , LcaseF (5′ GCACCGAGATTCA ACATGG3′ ) and LcaseR (5′ GGTTCTTGGATCTATGCGGTATTAG3′ ); L. delbrueckii 76 , LdelbF (5′ GGGTGATTTGTTGGACGCTAG3′ ) and LdelbR (5′ GCCGCCTTTCAAACTTGAATC3′ ); L. fermentum 77 , LfermF (5′ GCACC TGATTGATTTTGGTCG3′ ) and LactoR (5′ GTCCATTGTGGAAGATTCCC3′ ); L. plantarum 78 sgLplaF (5′ CTCTGGTATTGATTGGTGCTTGCAT3′ ) and sgLplaR (5′ GTTCGCCACTCACTCAAATGTAAA3′ ); L. rhamnosus 76 , LrhamF (5′ TGCTTGCATCTTGATTTAATTTTG3′ ) and LactoR (5′ GTCCATTG TGGAAGATTCCC3′ ); L. salivarius 77 , LsalivF (5′ CGAAACTTTCTTA CACCGAATGC3′ ) and LactoR (5′ GTCCATTGTGGAAGATTCCC3′ ). All measurements were performed in duplicate. Statistics. Power calculation is a prerequisite for any animal experiment accord ing to the local animal law and was performed using G* Power software v.3.1.9.2. Effect sizes were calculated from previously published experiments. Animals were randomly assigned to the respective body weightmatched groups, probiotic and control treatment were administered without knowledge of the treatment groups. The human pilot study was performed in an unblinded manner. Data analysis was performed by the investigators without knowledge of the treatment groups or treatment phase. All findings shown have been reproduced in at least two inde pendent experiments. Data are presented depending on their scale and distribution with arithmetic mean and standard deviation (mean ± s.e.m.) or median including 25-75% quartiles (25| 75 To analyse mouse blood pressure telemetry data, we conducted repeated meas urement analysis by using linear mixed models. We tested a random intercept versus a random intercept-slope model and selected the bestfit model. Data analysis was performed with R (v.3.1.1 R Foundation, Vienna, Austria) using the packages lme4 and nlme. A P value < 0.05 was considered statistically significant. Code availability. Code used for the 16S rDNA data analysis has been uploaded to a github repository (https://github.com/almlab/analysissaltresponsive). Software was obtained from publicly available sources; papers describing the software are cited in the text. Data availability. Raw files of the bacterial V4-V5 16S rRNA data and the L. murinus genome have been uploaded to the NCBI Sequence Read Archive as Bioproject PRJNA400793. Raw metagenomic data of the human study are avail able in the European Nucleotide Archive (ENA, accession number PRJEB22348). Reference datasets for the human metagenome analysis are accessible in the ENA (accession number ERP009422) and from https://www.hmpdacc.org/. Source Data for Figs 1-5 and Extended Data Figs 1, 3-10 are provided with the paper.
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Extended Data Figure 4 | Accuracy of AdaBoost and random forest classifiers. a, AdaBoost and random forest classifiers (trained on samples from days − 2, − 1 and 14) were used to predict the classification of all samples from HSD mice. The fraction of samples from each time point that the classifiers predicted as belonging to animals currently on a HSD is shown. The two runs of the random forest produced the same fractions, so only one line is shown for the two random forest classifiers. b, Time series for the remaining 7 OTUs important to the classifier. NSD and HSD phases are indicated by white and grey backgrounds. Mice (n = 12) were switched from NSD to HSD and back to NSD (subgroup of n = 8). Other control mice (n = 8) that remaind on NSD are shown in white. Box plots show median, IQR with whiskers of 1.5× IQR, circles represent samples from independent mice. nature research | life sciences reporting summary June 2017
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly.
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons The test results (e.g. p values) given as exact values whenever possible and with confidence intervals noted A summary of the descriptive statistics, including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
We state and cite all packages and software tools in the Methods section. Statistical analysis was performed using GraphPad Prism 6 and R (Version 3.1.1 R Foundation, Vienna, Austria) using the packages 'lme4' and 'nlme'. Furthermore the R 'survival', 'vegan', 'ape'; Python's scikit-learn module. Code used for the 16S rDNA data analysis has been uploaded to a github repository (https://github.com/almlab/analysis-salt-responsive). Software was obtained from publicly available sources; papers describing the software are cited in the text.
For all studies, we encourage code deposition in a community repository (e.g. GitHub). Authors must make computer code available to editors and reviewers upon request. The Nature Methods guidance for providing algorithms and software for publication may be useful for any submission.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No unique materials have been used. c. Report whether the cell lines were tested for mycoplasma contamination.
No eukaryotic cell lines were used, ony primary murine cells.
d. If any of the cell lines used in the paper are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
All animal experiments have been approved by local authorities, registration numbers are given in the Methods section. The following inbred mouse species were used: FVB/N, C57BL/6J. Supplier and age (10-12 weeks) of the mice as well as housing conditions are provided for each experiment in the Methods section. Only male mice were used.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
Only healthy male participants were recruited. Study population was homogeneous with regard to age, ethnicity, socioeconomic status, weight, BMI, diet (omnivore) and blood pressure. Baseline characteristics are shown in the Supplementary Information, Table 1 .
